NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

Peter Davis
@peter_brit
#dcvax $nwbo #gbm

I looked again at the 'hit piece' and forced correction of the article by Ethan Chen, Alexander L Ling, David A Reardon, E Antonio Chiocca. As my post referenced below, there were in fact a number of other false claims made which were not addressed by these authors however, I found it of particular interest that not only was the 'hit piece' the 'editor's choice' but actually when you click on the correction there is something really interesting. It appears they grudgingly corrected just one of a number of flawed and incorrect statements but in sheer desperation to continue negativity towards DCVax results, on the same correction article they have a list of four 'Recommended' articles, three of which are 'hit pieces' against DCVax:-

Recommended:

First results on the DCVax phase III trial: raising more questions than providing answersWolfgang Wick et al., Neuro-Oncology, 2018
https://academic.oup.com/neuro-oncology/article/20/10/1283/5077256?itm_medium=sidebar&itm_source=trendmd-widget&itm_campaign=Neuro-Oncology&itm_content=Neuro-Oncology_0

Dendritic cell vaccine trials in gliomas: Untangling the linesKelly M Hotchkiss et al., Neuro-Oncology
https://pubmed.ncbi.nlm.nih.gov/37289203/

This obvious bias got me to question who was the Editor in question and it turns out to be Susan M Chang who is the editor-in-chief, her profile attached below is very telling. Couple this along with the fact that Matthias Preusser (an author of another DCVax hit piece) is executive editor, E Antonio Chiocca Associate editor(author of hit piece and forced to correct) also:

Martin J. van den Bent,John de Groot, David A. Reardon and Susan Short, who have all co-authored 'hit pieces' against DCVax are on the Editorial Board

Not only serious attempts to attack DCVax's results but a coordinated attack it seems all from one journal and assisted by the editor-in-chief. Not on of these Doctors found anything wrong with the original article ? 🤔

#dcvax #allsolidtumors $nwbo #gbm

In a nutshell...

I asked Microsoft's AI to provide the following response to the article by Ethan Chen, Alexander L Ling, David A Reardon, E Antonio Chiocca

Thank you for your question. I have analysed and commented on the article by Chen…

— Peter Davis (@peter_brit) November 29, 2023

#dcvax $nwbo #gbm

Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma

Published: 05 April 2024

Hilarious.. In this recent article the authors grudgingly accept that "DCVax-L in recurrent and newly diagnosed GBM reported a survival benefit"but… pic.twitter.com/DAP4wYZeuI

— Peter Davis (@peter_brit) April 12, 2024

https://academic.oup.com/neuro-oncology/pages/Editorial_Board

https://ucsfhealth.org/providers/dr-susan-chang#:~:text=Susan%20Chang%20is%20a%20neuro,at%20the%20Brain%20Tumor%20Center.

https://linkedin.com/posts/angelo-dipasquale-302139135_autologous-tumor-lysate-loaded-dendritic-activity-7013210935230119936-1nHf/?trk=public_profile_like_view

https://academic.oup.com/neuro-oncology/article/26/2/211/7444576

https://academic.oup.com/neuro-oncology/article/26/4/779/7477448